MN/CA9 gene expression as a potential tumor marker for renal cell carcinoma

被引:0
|
作者
Pamposh Raina
S. K. Singh
Anil K. Goswami
Manoj Kumar Kashyap
Madhu Khullar
S. K. Sharma
Kailash Chander Barwal
机构
[1] Indira Gandhi Medical College,Department of Urology
[2] Postgraduate Institute of Medical Education & Research,Department of Urology
[3] Postgraduate Institute of Medical Education & Research,Department of Experimental Medicine and Biotechnology
[4] Amity University Haryana,Amity Stem Cell Institute, Amity Medical School
[5] Amity Education Valley,undefined
来源
关键词
RT-PCR; cDNA synthesis; Renal cell carcinoma; RCC; Blood; Urine;
D O I
暂无
中图分类号
学科分类号
摘要
MN/CA9 is a cell surface glycoprotein and a tumor-associated antigen. It plays a crucial role in the regulation of cell proliferation and oncogenesis. There is no ideal tumor marker currently available for renal cell carcinoma (RCC) with sufficient sensitivity and specificity. Therefore, we studied MN/CA9 gene expression in the tumor tissue, apparently normal kidney tissue, preoperative blood, and urine samples of patients with RCC. We included thirty cases of renal tumors (26 RCC and 4 benign tumors) in the study. We applied an RT-PCR assay for MN/CA9 gene expression to 26 RCC kidney tumor samples and four benign kidney tumor tissue samples. We also evaluated MN/CA9 gene expression in preoperative blood and urine samples of 15 of these cases. Additionally, thirty-five grossly normal renal tissue samples, including 21 from kidneys with RCC, were also evaluated for gene expression. The RT-PCR analysis revealed that twenty-one out of 26 RCC tissue samples showed MN/CA9 gene expression compared to three out of 35 non-malignant renal tissue samples (p < 0.05). Two out of four benign renal tissue samples also expressed this gene. We also observed MN/CA9 gene expression in nine out of 15 blood samples and four out of 15 urine samples. All patients with urinary MN/CA9 gene expression showed expression in blood and tumor tissue samples. We found a correlation in terms of MN/CA9 expression between blood and tumor tissue samples of RCC patients as those who exhibit MN/CA9 expression in blood were also positive at the tumor tissue levels. The difference in MN/CA9 gene expression in tumor tissue, blood, and urine samples in relation to the stage of the disease, nuclear grade, and histological cell-type was not statistically significant. However, all the three patients who had metastatic RCC had MN/CA9 gene expression in their blood. The existence of a tumor-associated antigen such as MN/CA9 may present a possible target for molecular diagnosis and management of RCC.
引用
收藏
页码:333 / 343
页数:10
相关论文
共 50 条
  • [31] Clinicopathological study and immunohistochemical expression of CA9 in cystic multilocular renal cell carcinomas
    Li, G.
    Badin, G.
    Berremila, S.
    Obadia, F.
    Tostain, J.
    Peoc'h, M.
    PROGRES EN UROLOGIE, 2012, 22 (10): : 572 - 576
  • [32] Use of CA9 gene single nucleotide polymorphisms to predict prognosis and treatment response of metastatic renal cell carcinoma
    de Martino, M.
    Klatte, T.
    Seligson, D. B.
    LaRochelle, J.
    Shuch, B.
    Caliliw, R. R.
    Li, Z.
    Kabbinavar, F. F.
    Pantuck, A. J.
    Belldegrun, A. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] Heterogeneous expression of MN/CA9-G250 tumor associated antigen (TAA) in renal cell carcinoma (RCC)
    Drachenberg, DE
    Mena, OJ
    Ivanov, SV
    Linehan, WM
    Childs, RC
    JOURNAL OF UROLOGY, 2002, 167 (04): : 126 - 126
  • [34] CA9 as a biomarker in preoperative biopsy of small solid renal masses for diagnosis of clear cell renal cell carcinoma
    Li, Guorong
    Feng, Gang
    Zhao, An
    Peoc'h, Michel
    Cottier, Michele
    Mottet, Nicolas
    BIOMARKERS, 2017, 22 (02) : 123 - 126
  • [35] Inhibition of carbonic anhydrase IX (CA9) sensitizes renal cell carcinoma to ionizing radiation
    Duivenvoorden, Wilhelmina C. M.
    Hopmans, Sarah N.
    Gallino, Daniel
    Farrell, Thomas
    Gerdes, Carrie
    Glennie, Diana
    Lukka, Himu
    Pinthus, Jehonathan H.
    ONCOLOGY REPORTS, 2015, 34 (04) : 1968 - 1976
  • [36] Serum CA9 messenger RNA expression for molecular diagnosis of conventional renal cell cancer
    Feng, G.
    Li, G.
    Gentil-Perret, A.
    Genin, C.
    Tostain, J.
    BULLETIN DU CANCER, 2008, 95 : S12 - S12
  • [37] Characterization of carbonic anhydrase 9 (CA9) as an endogenous hypoxia marker in live tumor cells
    Vordermark, D
    Katzer, A
    Kaffer, A
    Riedel, S
    Flentje, M
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S328 - S329
  • [38] Carbonic Anhydrase 9 (CA9) and Caspase-9 (CASP-9) Expression in Clear Cell Renal Cell Carcinoma (CRCC): Diagnostic, Prognostic and Therapeutic Implications
    Kiremitci, S.
    Kankaya, D.
    Tulunay, O.
    Baltaci, S.
    MODERN PATHOLOGY, 2010, 23 : 200A - 201A
  • [39] Carbonic Anhydrase 9 (CA9) and Caspase-9 (CASP-9) Expression in Clear Cell Renal Cell Carcinoma (CRCC): Diagnostic, Prognostic and Therapeutic Implications
    Kiremitci, S.
    Kankaya, D.
    Tulunay, O.
    Baltaci, S.
    LABORATORY INVESTIGATION, 2010, 90 : 200A - 201A
  • [40] Impacts of CA9 Gene Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathologic Characteristics in Taiwan
    Wang, Shian-Shiang
    Liu, Yu-Fan
    Ou, Yen-Chuan
    Chen, Chuan-Shu
    Li, Jian-Ri
    Yang, Shun-Fa
    PLOS ONE, 2013, 8 (12):